Prelude Capital Management, LLC Supernus Pharmaceuticals, Inc. Call Options Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$25.47 - $33.37 $236,871 - $310,341
-9,300 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$29.96 - $38.87 $41,944 - $54,418
1,400 Added 17.72%
9,300 $308,000
Q1 2019

May 15, 2019
SELL
$32.77 - $41.99 $478,442 - $613,054
-14,600 Reduced 64.89%
7,900 $277,000
Q3 2018

Nov 14, 2018
BUY
$42.7 - $56.55 $960,750 - $1.27 Million
22,500 New
22,500 $1.13 Million

Others Institutions Holding SUPN

# of Institutions
272
Shares Held
60.5M
Call Options Held
47.9K
Put Options Held
13.1K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.02B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email